Yipinhong Pharmaceutical starts share buyback program

Yipinhong Pharmaceutical Group Co., Ltd. announced on December 17, 2025, that it has initiated a share buyback program. The company repurchased 706,000 shares, representing 0.16% of its total share capital, through centralized bidding on the secondary market. The highest price paid was RMB 33.42 per share, with a lowest price of RMB 32.12 per share, resulting in an average price of RMB 32.75 per share. The total transaction amounted to RMB 23,119,500, excluding transaction fees.

This initial repurchase aligns with the company's previously approved plan, which seeks to repurchase shares valued between RMB 100,000,000 and RMB 200,000,000 at a maximum price of RMB 70.00 per share. The buyback period is set for three months from the date of board approval. The decision, made during the fourth board meeting on December 15, 2025, falls within the board's authority and does not require shareholder approval.

Yipinhong Pharmaceutical has affirmed its commitment to continue the share buyback program in accordance with market conditions and relevant regulations. The company will adhere to information disclosure requirements to ensure transparency for investors. Investors are advised to exercise caution due to market risks.